Anchor Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1M | Sell |
13,180
-248
| -2% | -$251K | 1.01% | 20 |
|
|
2025
Q4 | $14.4M | Sell |
13,428
-822
| -6% | -$786K | 1.17% | 19 |
|
|
2025
Q3 | $10.9M | Buy |
14,250
+196
| +1% | +$146K | 0.9% | 23 |
|
|
2025
Q2 | $11M | Buy |
14,054
+38
| +0.3% | +$29.5K | 0.96% | 20 |
|
|
2025
Q1 | $11.6M | Sell |
14,016
-29
| -0.2% | -$24.1K | 1.08% | 19 |
|
|
2024
Q4 | $10.8M | Buy |
14,045
+95
| +0.7% | +$78.7K | 1.01% | 22 |
|
|
2024
Q3 | $12.4M | Sell |
13,950
-16
| -0.1% | -$14.4K | 1.17% | 18 |
|
|
2024
Q2 | $12.6M | Buy |
13,966
+131
| +0.9% | +$105K | 1.3% | 16 |
|
|
2024
Q1 | $10.8M | Sell |
13,835
-374
| -3% | -$266K | 1.13% | 19 |
|
|
2023
Q4 | $8.28M | Buy |
14,209
+249
| +2% | +$145K | 0.95% | 24 |
|
|
2023
Q3 | $7.5M | Buy |
13,960
+96
| +0.7% | +$49.5K | 0.98% | 23 |
|
|
2023
Q2 | $6.5M | Buy |
13,864
+419
| +3% | +$176K | 0.83% | 30 |
|
|
2023
Q1 | $4.62M | Buy |
13,445
+46
| +0.3% | +$15.5K | 0.63% | 42 |
|
|
2022
Q4 | $4.9M | Sell |
13,399
-501
| -4% | -$178K | 0.7% | 35 |
|
|
2022
Q3 | $4.49M | Sell |
13,900
-121
| -0.9% | -$38.3K | 0.7% | 36 |
|
|
2022
Q2 | $4.55M | Sell |
14,021
-157
| -1% | -$47.1K | 0.66% | 39 |
|
|
2022
Q1 | $4.06M | Sell |
14,178
-828
| -6% | -$213K | 0.51% | 53 |
|
|
2021
Q4 | $4.14M | Buy |
15,006
+158
| +1% | +$40.1K | 0.51% | 55 |
|
|
2021
Q3 | $3.43M | Buy |
14,848
+79
| +0.5% | +$19.5K | 0.48% | 62 |
|
|
2021
Q2 | $3.39M | Buy |
14,769
+222
| +2% | +$44.6K | 0.47% | 64 |
|
|
2021
Q1 | $2.72M | Buy |
14,547
+70
| +0.5% | +$13.7K | 0.41% | 69 |
|
|
2020
Q4 | $2.44M | Buy |
14,477
+1,200
| +9% | +$179K | 0.44% | 71 |
|
|
2020
Q3 | $1.97M | Hold |
13,277
| – | – | 0.4% | 72 |
|
|
2020
Q2 | $2.18M | Hold |
13,277
| – | – | 0.49% | 60 |
|
|
2020
Q1 | $1.84M | Buy |
13,277
+813
| +7% | +$112K | 0.48% | 65 |
|
|
2019
Q4 | $1.64M | Buy |
12,464
+1,000
| +9% | +$116K | 0.35% | 88 |
|
|
2019
Q3 | $1.28M | Buy |
11,464
+25
| +0.2% | +$2.78K | 0.3% | 101 |
|
|
2019
Q2 | $1.27M | Hold |
11,439
| – | – | 0.3% | 93 |
|
|
2019
Q1 | $1.48M | Hold |
11,439
| – | – | 0.37% | 77 |
|
|
2018
Q4 | $1.32M | Sell |
11,439
-4,200
| -27% | -$469K | 0.38% | 75 |
|
|
2018
Q3 | $1.68M | Sell |
15,639
-500
| -3% | -$50K | 0.38% | 75 |
|
|
2018
Q2 | $1.38M | Buy |
16,139
+433
| +3% | +$35.6K | 0.34% | 82 |
|
|
2018
Q1 | $1.22M | Hold |
15,706
| – | – | 0.32% | 90 |
|
|
2017
Q4 | $1.33M | Hold |
15,706
| – | – | 0.35% | 81 |
|
|
2017
Q3 | $1.34M | Hold |
15,706
| – | – | 0.39% | 74 |
|
|
2017
Q2 | $1.29M | Sell |
15,706
-200
| -1% | -$16.3K | 0.43% | 70 |
|
|
2017
Q1 | $1.34M | Buy |
15,906
+1,400
| +10% | +$112K | 0.46% | 65 |
|
|
2016
Q4 | $1.07M | Sell |
14,506
-100
| -0.7% | -$7.45K | 0.4% | 74 |
|
|
2016
Q3 | $1.17M | Buy |
14,606
+1,500
| +11% | +$120K | 0.45% | 68 |
|
|
2016
Q2 | $1.03M | Buy |
13,106
+2,400
| +22% | +$181K | 0.41% | 74 |
|
|
2016
Q1 | $771K | Buy |
+10,706
| New | +$810K | 0.32% | 86 |
|
Other funds holding LLY
VCM
VPM
Anchor Investment Management's LLY Position: Q1 2026 in Review
Anchor Investment Management reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $251K and leaving 13,180 shares worth $12.1M. The position accounts for 1.01% of the portfolio, ranked #20.
Anchor Investment Management first reported a position in LLY in Q1 2016 and has held it in 41 quarters since. The position peaked at $14.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Anchor Investment Management held 13,180 shares of Eli Lilly worth $12.1M as of Q1 2026.
- Anchor Investment Management sold 248 Eli Lilly shares in Q1 2026, an estimated $251K.
- Eli Lilly made up 1.01% of Anchor Investment Management's portfolio in Q1 2026, its #20 holding.
- Anchor Investment Management first reported a position in Eli Lilly in Q1 2016 and has held it in 41 quarters since.
- Anchor Investment Management's Eli Lilly position peaked at $14.4M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.